METAVIA INC. Proceeds from Long-Term Debt Issued
METAVIA INC. (MTVA) reported Proceeds from Long-Term Debt Issued of $10.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2019-03-18
- METAVIA INC. proceeds from issuance of long-term debt for the quarter ending 2017-12-31 was $0.00.
- METAVIA INC. proceeds from issuance of long-term debt for fiscal 2017 was $10.00M, a 277.22% increase from fiscal 2016.
- METAVIA INC. proceeds from issuance of long-term debt for fiscal 2016 was $2.65M, a 52.32% decline from fiscal 2015.
- METAVIA INC. proceeds from issuance of long-term debt for fiscal 2015 was $5.56M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $10.00M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $10.00M 10-Q · filed 2018-11-08 | ||
| 2016-12-31 | $2.65M 10-K · filed 2019-03-18 | ||
| 2015-12-31 | $5.56M 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |